首页> 外国专利> AN ANTI-ANGIOGENIC STATE IN MICE AND HUMANS WITH RETINAL PHOTORECPTOR CELL DEGENERATION

AN ANTI-ANGIOGENIC STATE IN MICE AND HUMANS WITH RETINAL PHOTORECPTOR CELL DEGENERATION

机译:视网膜光祖细胞变性的小鼠和人类的抗血管生成状态

摘要

Neonatal mice with classic inherited retinal degeneration (Pdebrd1/Pdebrd1) are disclosed which fail to mount reactive retinal neovascularization in a mouse model of oxygen-induced proliferative retinopathy. Also disclosed is a comparable human paradigm: spontaneous regression of retinal neovascularization associated with long-standing diabetes mellitus which occurs when retinitis pigmentosa becomes clinically evident. Both mouse and human data indicate that reactive retinal neovascularization either fails to develop or regresses when the number of photoreceptor cells is markedly reduced. The results show that a functional mechanism underlying this anti-angiogenic state is failure of the predicted up-regulation of vascular endothelial growth factor (VEGF), although other growth factors may also be involved. Preventive and therapeutic methods useful against both proliferative and degenerative retinopathies are also disclosed.
机译:公开了具有经典遗传性视网膜变性(Pdeb rd1 / Pdeb rd 1)的新生小鼠,其在氧诱导的增生性视网膜病的小鼠模型中未能引起反应性视网膜新血管形成。还公开了可比的人类范例:当色素性视网膜炎变得临床上明显时,与长期存在的糖尿病有关的视网膜新血管形成的自发性消退。小鼠和人类的数据均表明,当感光细胞的数量明显减少时,反应性视网膜新血管形成要么无法发展,要么退化。结果表明,这种抗血管生成状态的潜在功能机制是预测的血管内皮生长因子(VEGF)上调失败,尽管也可能涉及其他生长因子。还公开了对增殖性和变性性视网膜病有用的预防和治疗方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号